Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials
de Vries ST, Pena MJ, Tye SC, et al.
Diabetologia. Pub. online 10 Dec 2024.
Leggi